Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by edroseon Aug 22, 2022 7:01pm
225 Views
Post# 34912751

Which will the judge believe prometics scientists with great

Which will the judge believe prometics scientists with greatReputation and track record like Lynne gagnon who discovered 3tc; ( btw new management got her to leave after takeover) or the new management and their scientists who said 4050 had no value suddenly even if they had excellent results  and prometic patented plasma technology with excellent results and much better than the old Cohn technology  and fda approved ryplasim therefore confirming pli's technology is safe and effective .  Don't forget they gave away ryplasim and plasma division just before fda approved it.  Ask yourself  why would a company  would give away a great asset /new drug 
just before approval and the patented technology that can separate other great plasma products from same liter of plasma.  As was presented to investors at last 2 agm's before takeover 

WHO WILL THE JUDGE BELIEVE 
<< Previous
Bullboard Posts
Next >>